Smoking cessation in advanced-stage cancer patients can extend life by about one year, highlighting its importance in cancer ...
PLYMOUTH MEETING, PA [October 9, 2025] — New research published online in JNCCN—Journal of the National Comprehensive Cancer Network finds that people with cancer who quit smoking had a much lower ...
Achieve Life Sciences Inc. ACHV said Tuesday a second confirmatory late-stage trial of its cytisinicline for quitting smoking and nicotine dependence achieved positive results, showing a statistically ...
Efforts to discourage smoking have steadily reduced its prevalence from 27.8% of the global population in 1990 to 19.6% in 2019. However, the total number of people who smoke has actually increased ...
Positive Phase 2 ORCA-V1 trial results show cytisinicline's potential in helping users quit vaping, with an odds ratio of 2.6 compared to placebo, suggesting a strong case for FDA approval.
Hosted on MSN
Study confirms it's 'never too late' to see survival benefits from quitting smoking—even with late-stage cancer
New research published online in the Journal of the National Comprehensive Cancer Network finds that people with cancer who quit smoking had a much lower risk of dying within two years compared to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback